patient also has comorbid obesity with BMI of 38.2 which is expected to improve with GLP-1 therapy" covers both indications while keeping diabetes as the primary treatment rationale
Your provider reviews your medical history, including conditions like diabetes, hypertension, or heart disease
Berg and his colleagues found higher levels of glutathione, an antioxidant made by the body, inside metastatic tumor cells in treated mice compared with untreated mice
What we do in that scenario is keep patients at the lowest dose before escalating, to let their body adjust to the medication. While the low and slow method can work for many people, with side effects often leveling out over time, for some, they arent tolerable, even at the lowest starting dose
Here are some key rules to keep in mind: Never take two doses too close together
Our app gives patients the ability to do this while remaining HIPAA compliant